Kissei Pharmaceutical Co Financial Overview
Kissei Pharmaceutical Co's market cap is currently ¥186.47B. The company's EPS TTM is ¥78.93; its P/E ratio is 13.54; and it has a dividend yield of 2.48%. Kissei Pharmaceutical Co is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is ¥-38.50. See an overview of income statement, balance sheet, and cash flow financials.
